Hyperuricaemia: prevalence and association with mortality in an elderly Finnish population
Open Access
Abstract
Objective To establish the prevalence of hyperuricaemia in an elderly Finnish cohort and to assess its association with comorbidities and mortality. Design Prospective cohort study. Setting Good Ageing in Lahti Region study, Finland 2002–2012 (mortality data analysed until 2018). Participants 2673 participants (mean age 64 years; 47% men). Primary and secondary outcome measures Prevalence of hyperuricaemia in the study population was detected. Associations between hyperuricaemia and mortality were assessed using multivariable adjusted Cox proportional hazards models. Methods Data from a prospective, population-based study of elderly people (52–76 years) in the Lahti region, Finland, were used. Information on serum uric acid (SUA) levels as well as several other laboratory variables, comorbidities, lifestyle habits and socioeconomic factors was collected, and the association between SUA level and mortality in a 15-year follow-up period was analysed. Results Of 2673 elderly Finnish persons included in the study 1197 (48%) were hyperuricaemic. Hyperuricaemia was extremely prevalent in men (60%). There was an association between elevated SUA and mortality which remained after adjustment for potential confounding factors (age, gender, education, smoking status, body mass index, hypertension and dyslipidaemia). The adjusted HR for all-cause mortality among clearly hyperuricaemic individuals with SUA≥420 µmol/L compared with normouricaemic individuals (SUAConclusions Hyperuricaemia is very prevalent in the elderly Finnish population and is independently associated with increased mortality.Keywords
This publication has 50 references indexed in Scilit:
- Serum uric acid and the risk of mortality during 23 years follow-up in the Scottish Heart Health Extended Cohort StudyAtherosclerosis, 2014
- Definition of hyperuricemia and gouty conditionsCurrent Opinion in Rheumatology, 2014
- Allopurinol Reduces Left Ventricular Mass in Patients With Type 2 Diabetes and Left Ventricular HypertrophyJACC, 2013
- Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based studyAnnals of the Rheumatic Diseases, 2013
- Mediterranean Diet and Risk of Hyperuricemia in Elderly Participants at High Cardiovascular RiskThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2013
- High-Dose Allopurinol Reduces Left Ventricular Mass in Patients With Ischemic Heart DiseaseJACC, 2013
- Uric Acid Level as a Risk Factor for Cardiovascular and All-Cause Mortality in Middle-aged MenArchives of internal medicine (1960), 2004
- Relations of Hyperuricemia with the Various Components of the Insulin Resistance Syndrome in Young Black and White Adults: The CARDIA StudyAnnals of Epidemiology, 1998
- Hyperuricaemia and Risk of Cardiovascular Disease and Overall DeathActa Medica Scandinavica, 1988
- Hyperuricemia as a Risk Factor for Cardiovascular MortalityActa Medica Scandinavica, 1982